VanEck Biotech ETF
BBH
116 hedge funds and large institutions have $159M invested in VanEck Biotech ETF in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 34 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
5% more funds holding
Funds holding: 110 → 116 (+6)
5% more capital invested
Capital invested by funds: $152M → $159M (+$7.05M)
0.48% less ownership
Funds ownership: 33.56% → 33.09% (-0.48%)
38% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 34
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$8.75M |
| 2 |
JP Morgan Chase
New York
|
+$2.81M |
| 3 |
FFN
Focus Financial Network
Minneapolis,
Minnesota
|
+$2.17M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$992K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$756K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
-$11.2M |
| 2 |
LPL Financial
San Diego,
California
|
-$3.41M |
| 3 |
FFP
FourThought Financial Partners
Venice,
Florida
|
-$615K |
| 4 |
PGFC
Peapack-Gladstone Financial Corp
Bedminster,
New Jersey
|
-$547K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$465K |
BBH Hedge Fund Activity: Q4 2023 in Review
116 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2023, worth a combined $159M — up 4.7% from $152M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BBH positions and 9 closed out — a net gain of 8 holders — while 21 added to existing stakes and 34 trimmed.
The largest buyer was Bank of America, adding an estimated $8.75M. The largest seller was Miller Investment Management, cutting an estimated $11.2M.
- 116 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2023, up from 110 in Q3 2023.
- Funds reported $159M of VanEck Biotech ETF stock for Q4 2023, up 4.7% quarter-over-quarter.
- 17 funds opened new VanEck Biotech ETF positions in Q4 2023 and 9 closed out, a net change of +8 holders.
- The largest VanEck Biotech ETF buyer in Q4 2023 was Bank of America, an estimated $8.75M added.
- The largest VanEck Biotech ETF seller in Q4 2023 was Miller Investment Management, an estimated $11.2M sold.
Based on aggregated 13F filings for Q4 2023.